Find Centhaquine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Centhaquin, 57961-90-7, Compound-7173, Pmz-2010, Centhaquine [usan], Centhaquine;pmz-2010
Molecular Formula
C22H25N3
Molecular Weight
331.5  g/mol
InChI Key
UJNWGFBJUHIJKK-UHFFFAOYSA-N
FDA UNII
QD4VI0J9T5

Centhaquine
Centhaquine is under investigation in clinical trial NCT04045327 (Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock).
1 2D Structure

Centhaquine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2-[4-(3-methylphenyl)piperazin-1-yl]ethyl]quinoline
2.1.2 InChI
InChI=1S/C22H25N3/c1-18-5-4-7-21(17-18)25-15-13-24(14-16-25)12-11-20-10-9-19-6-2-3-8-22(19)23-20/h2-10,17H,11-16H2,1H3
2.1.3 InChI Key
UJNWGFBJUHIJKK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC(=CC=C1)N2CCN(CC2)CCC3=NC4=CC=CC=C4C=C3
2.2 Other Identifiers
2.2.1 UNII
QD4VI0J9T5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(bis(2-quinolyl)ethyl)-4-m-tolylpiperazine

2. Centhaquin

2.3.2 Depositor-Supplied Synonyms

1. Centhaquin

2. 57961-90-7

3. Compound-7173

4. Pmz-2010

5. Centhaquine [usan]

6. Centhaquine;pmz-2010

7. Qd4vi0j9t5

8. 2-[2-[4-(3-methylphenyl)piperazin-1-yl]ethyl]quinoline

9. Pmz2010

10. 2-(2-(4-(m-tolyl)piperazin-1-yl)ethyl)quinoline

11. Quinoline, 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl)-

12. Compound 7173

13. Brn 0563681

14. 2-(2-(4-(3-methylphenyl)piperazin-1-yl)ethyl)quinoline

15. 1-(beta(2-quinolyl)ethyl)-4-m-tolylpiperazine

16. 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl)quinoline

17. Centhaquine [inn]

18. Unii-qd4vi0j9t5

19. Zinc1105

20. Chembl4594437

21. Schembl10029638

22. Dtxsid40206680

23. Bcp31600

24. Centhaquin (centhaquine,pmz-2010)

25. Who 11138

26. Sb18795

27. Ac-35784

28. Hy-106690

29. Cs-0026357

30. 1-(bis(2-quinolyl)ethyl)-4-m-tolylpiperazine

31. 2-(2-(4-m-tolylpiperazin-1-yl)ethyl)quinoline

32. Pmz-2010; Pmz2010; Pmz 2010; Compound 7173

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 331.5 g/mol
Molecular Formula C22H25N3
XLogP34.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Exact Mass331.204847810 g/mol
Monoisotopic Mass331.204847810 g/mol
Topological Polar Surface Area19.4 Ų
Heavy Atom Count25
Formal Charge0
Complexity404
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty